Analyst firms · Morgan Stanley · TFX
Morgan Stanley TFX price target and rating history
Teleflex Incorporated (TFX) · Health Care
Morgan Stanley rates Teleflex Incorporated (TFX) Overweight with a $261 price target, as of its latest action on Dec 4, 2023. It has published 5 rating actions on TFX since October 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a TFX price target in the last 12 months, the median target is $155.
- Current rating
- Overweight
- Price target
- $261
- Median target, all firms
- $155
- Actions on TFX
- 5
Morgan Stanley price target on TFX
Every Morgan Stanley rating on TFX
- Dec 4, 2023
- May 30, 2023
- Feb 25, 2022
- Jan 7, 2022
- Oct 29, 2021
How other firms rate TFX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Buy | $158 | Sep 28, 2026 |
| UBS | Neutral | $145 | Jul 28, 2026 |
| BMO Capital Markets | Outperform | $159 | Jul 9, 2026 |
| Piper Sandler | Overweight | $160 | Jun 8, 2026 |
| RBC Capital Markets | Outperform | $155 | May 8, 2026 |
| Raymond James | Outperform | $128 | Mar 27, 2026 |
| Needham | Buy | $138 | Jan 27, 2026 |
Questions about Morgan Stanley and TFX
- What is Morgan Stanley's price target for TFX?
- Morgan Stanley's latest stated price target for Teleflex Incorporated (TFX) is $261, from its action on Dec 4, 2023.
- What is Morgan Stanley's rating on TFX?
- Morgan Stanley rates TFX Overweight, a bullish rating, as of Dec 4, 2023.
- When did Morgan Stanley last change its view on TFX?
- On Dec 4, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $261.
- How does Morgan Stanley's TFX target compare with other analysts?
- Across 7 firms with a TFX price target in the last 12 months, the median target is $155.
More TFX rating histories
All Morgan Stanley ratingsTFX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.